Cindilimab、IBI310、Capecitabine、Oxaliplatin
Phase 2
Cindilimab、IBI310、Capecitabine、Oxaliplatin is one of 5 therapeutic programs targeting Locally Advanced Rectal Adenocarcinoma. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
5 competitors in Locally Advanced Rectal Adenocarcinoma
#DrugCompanyPhaseTrials
1Yervoy
Bristol-Myers SquibbPhase 2
Opdivo
Bristol-Myers SquibbPhase 2
Cindilimab、IBI310、Capecitabine、Oxaliplatin
XXijing Hospital
Phase 2
Consolidation Therapy
IInstitute of Hematology & Blood Diseases Hospital, China
Phase 1
Papaverine
WWestern Galilee Hospital-Nahariya
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 2[1]
- Company
- XXijing Hospital